α-Synuclein in Parkinson disease and other neurodegenerative disorders.

Abstract

With the aging population in the Western hemisphere, neurodegenerative parkinsonism and dementia will become two of the great public health challenges of this century. A major pillar in the effort to treat these conditions will be the shift from symptomatic treatment to disease modifying therapy. This step will absolutely require cheap and reliable… (More)
DOI: 10.1515/CCLM.2011.077

Topics

  • Presentations referencing similar topics